Fluorogenic Imaging Enables the Identification of Phosphoramidate Antibody–Drug Conjugate Linkers
Preprint
- 22 December 2025
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Modular, tunable linker chemistries that are stable in circulation yet selectively cleaved are needed to realize the therapeutic potential of antibody drug conjugates (ADCs). Near-infrared (NIR) fluorogenic imaging using norcyanine carbamate (CyBam) probes can quantitatively compare ADC linkers across in vitro and in vivo settings. A series of substituted CyBams modified with phosphoramidates, peptide, and control triggers were conjugated to the EGFR-targeting monoclonal antibody (mAb) panitumumab. Imaging in cellular and in vivo settings reveal the potential for novel phosphoramidate linkers, showing selective cellular activation, excellent tumor-localization, and reduced liver signal compared to conventional proteolytic linkers. Guided by these imaging results, monomethyl auristatin E (MMAE) conjugates bearing the new linkers were prepared and display picomolar potency, receptor dependent activity and promising in vivo tumor growth inhibition. In total, these studies demonstrate that quantitative fluorogenic imaging can enable the discovery and prioritization of new ADC linkers.Keywords
All Related Versions
- Version 1, 2025-12-22, ChemRxiv
- Published version: Bioconjugate Chemistry, 37 (2), 351.
Funding Information
- National Institutes of Health (BC011506)
- National Institutes of Health (BC011564)
This publication has 33 references indexed in Scilit:
- Linker Design for the Antibody Drug Conjugates: A Comprehensive ReviewChemMedChem, 2025
- Benzyl Ammonium Carbamates Undergo Two‐Step Linker Cleavage and Improve the Properties of Antibody ConjugatesAngewandte Chemie International Edition, 2024
- Dynamic Long-Range Interactions Influence Substrate Binding and Catalysis by Human Histidine Triad Nucleotide-Binding Proteins (HINTs), Key Regulators of Multiple Cellular Processes and Activators of Antiviral ProTidesBiochemistry, 2022
- Structure–Activity Relationships of Antibody-Drug Conjugates: A Systematic Review of Chemistry on the Trastuzumab ScaffoldBioconjugate Chemistry, 2022
- Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer CellsBioconjugate Chemistry, 2021
- Quantification of Drug Release Degree In Vivo Using Antibody-Guided, Dual-NIR-Dye Ratiometric SystemAnalytical Chemistry, 2021
- Recent advances of thiol-selective bioconjugation reactionsCurrent Opinion in Chemical Biology, 2020
- Ethynylphosphonamidates for the Rapid and Cysteine‐Selective Generation of Efficacious Antibody–Drug ConjugatesAngewandte Chemie International Edition, 2019
- Cysteine‐Selective Phosphonamidate Electrophiles for Modular Protein BioconjugationsAngewandte Chemie International Edition, 2019
- Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged non-chiral internucleotide 3′-phosphoramidate linkageTetrahedron Letters, 1992